Cardiovascular Disease

Menopausal hormone therapy does not affect risks for cardiovascular disease or type 2 diabetes, according to findings from a study of middle-aged postmenopausal women in South Korea published in Menopause.

The benefits of statin use to prevent cardiovascular disease and mortality in patients with rheumatoid arthritis outweigh the risks for developing type 2 diabetes, according to data presented at ACR Convergence 2021.

The 19th annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease conference will take place in-person with a virtual component for remote participants next month.

Women with a bone mineral density greater than 1.085 g/cm2 may have less risk for cardiovascular disease than those with a lower BMD, according to study data published in Nutrition, Metabolism & Cardiovascular Diseases.

The CDC is urging all individuals with a chronic health condition such as heart disease to receive an influenza vaccination in preparation for the 2021-2022 flu season.

A substantial number of deaths among men with metastatic prostate cancer resulted from noncancer causes, including cardiovascular disease, according to a retrospective cohort study published in JAMA Network Open.

The kidney community is in a sweet spot with the availability of new and effective therapies that prevent the progression of both diabetic and non-diabetic kidney diseases.

About 25% of U.S. adults have nonalcoholic fatty liver disease, which is the most common chronic liver condition in the U.S., according to the American Liver Foundation.

The FDA has issued voluntary guidelines that are intended to lower excess sodium intake from packaged, processed and prepared foods, the agency said.

Changes in menstrual cycle lengths as women approach menopause may indicate CVD risks, according to a study published in Menopause.